Yilmaz, G.; Çoban, H.; Sarioglu, N.; Erel, F.; Yılmaz, M.A.; Çolak, M.; Yumrukuz Şenel, M.; Hismioğulları, A.A.
Could Hepcidin Be a New Biomarker in Patients with Idiopathic Pulmonary Fibrosis (IPF)? J. Clin. Med. 2024, 13, 6823.
https://doi.org/10.3390/jcm13226823
AMA Style
Yilmaz G, Çoban H, Sarioglu N, Erel F, Yılmaz MA, Çolak M, Yumrukuz Şenel M, Hismioğulları AA.
Could Hepcidin Be a New Biomarker in Patients with Idiopathic Pulmonary Fibrosis (IPF)? Journal of Clinical Medicine. 2024; 13(22):6823.
https://doi.org/10.3390/jcm13226823
Chicago/Turabian Style
Yilmaz, Gulcin, Hikmet Çoban, Nurhan Sarioglu, Fuat Erel, Merve Akış Yılmaz, Mustafa Çolak, Merve Yumrukuz Şenel, and Adnan Adil Hismioğulları.
2024. "Could Hepcidin Be a New Biomarker in Patients with Idiopathic Pulmonary Fibrosis (IPF)?" Journal of Clinical Medicine 13, no. 22: 6823.
https://doi.org/10.3390/jcm13226823
APA Style
Yilmaz, G., Çoban, H., Sarioglu, N., Erel, F., Yılmaz, M. A., Çolak, M., Yumrukuz Şenel, M., & Hismioğulları, A. A.
(2024). Could Hepcidin Be a New Biomarker in Patients with Idiopathic Pulmonary Fibrosis (IPF)? Journal of Clinical Medicine, 13(22), 6823.
https://doi.org/10.3390/jcm13226823
